Pfizer’s subsidiary Biohaven has agreed to a settlement nearing $60 million to resolve allegations of false claims related to ...

Biohaven, acquired by Pfizer in 2022, allegedly took doctors to high-end restaurants and paid speaker honoraria for ...

The alleged violations occurred before Pfizer bought Biohaven and its migraine treatment three years ago for $11.6 billion.

Over the years, the U.S. Department of Justice (DOJ) has taken a host of drugmakers to task over alleged kickback payments ...

Pfizer subsidiary Biohaven allegedly gave physicians speaker honoraria and meals at high-end restaurants to induce them to ...

Biohaven wielded meals at high-end restaurants and paid speaking opportunities to induce healthcare providers to prescribe ...

The pharmaceutical giant Pfizer will pay nearly $60 million to resolve charges that a company it acquired paid kickbacks so ...

In a recent industry report focused on Biotechnology stocks, particularly those innovating in neurology and psychiatry, ...

Pfizer will pay $59.7 million to resolve charges that a company it acquired defrauded Medicare and other healthcare programs ...

SeaBridge Investment Advisors LLC decreased its stake in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) by 4.0% during the fourth quarter, according to the company in its most recent filing with ...

Pfizer (PFE) has agreed to pay nearly $60M to resolve allegations that its Biohaven unit paid kickbacks to induce ...

Jefferies has recently initiated Biohaven Ltd (BHVN) stock to Buy rating, as announced on September 16, 2024, according to Finviz. Earlier, on September 4, 2024, Bernstein had initiated the stock to ...